Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has ...
BioDlink, a leading global CDMO, extends its congratulations to Junshi Biosciences (HKEX-1877; SSE-688180), on receiving Investigational New Drug (IND) approval from China's National Medical Products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results